NervGen Pharma Corp. NGEN.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 431.77% | 17.83% | 34.12% | -47.54% | -40.78% |
| Total Receivables | 24.34% | -76.82% | -81.72% | 5,545.83% | 1,250.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1,851.98% | 2,059.68% | 42.41% | 31.75% | -44.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -58.69% | 148.94% | -72.39% | -12.67% | -0.21% |
| Total Current Assets | 423.17% | 36.32% | 25.84% | -44.07% | -39.48% |
|
|
|||||
| Total Current Assets | 423.17% | 36.32% | 25.84% | -44.07% | -39.48% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -16.22% | -9.78% | -7.64% | -14.30% | -11.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 411.82% | 35.00% | 24.99% | -43.52% | -39.10% |
|
|
|||||
| Total Accounts Payable | -27.53% | 11.94% | -13.79% | -91.76% | -92.98% |
| Total Accrued Expenses | -21.08% | 34.68% | -1.00% | 77.40% | 64.17% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -90.98% | -66.29% | -38.70% |
| Total Finance Division Other Current Liabilities | 198.61% | -2.46% | 33.28% | 5.14% | 9.44% |
| Total Other Current Liabilities | 198.61% | -2.46% | 33.28% | 5.14% | 9.44% |
| Total Current Liabilities | 133.34% | 8.49% | 22.52% | 17.28% | 16.71% |
|
|
|||||
| Total Current Liabilities | 133.34% | 8.49% | 22.52% | 17.28% | 16.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 133.34% | 8.49% | 22.46% | 16.99% | 16.27% |
|
|
|||||
| Common Stock & APIC | 52.66% | 34.81% | 33.12% | 9.02% | 10.85% |
| Retained Earnings | -11.11% | -44.05% | -50.04% | -24.26% | -30.90% |
| Treasury Stock & Other | 46.92% | 89.18% | 106.32% | 15.32% | 25.01% |
| Total Common Equity | 4,998.17% | 310.68% | 41.60% | -131.09% | -107.38% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4,998.17% | 310.68% | 41.60% | -131.09% | -107.38% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4,998.17% | 310.68% | 41.60% | -131.09% | -107.38% |
|
|
|||||